{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:13:13Z","timestamp":1774440793318,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.clbc.2024.07.011","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clbc.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:23:17Z","timestamp":1723076597000},"page":"e665-e680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["RETRACTED: Omitting axillary lymph node dissection is associated with an increased risk of regional recurrence in early stage breast cancer: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-8047","authenticated-orcid":false,"given":"Jorge Henrique Cavalcanti Orestes","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-7442","authenticated-orcid":false,"given":"Isabella Christina Amaral","family":"de Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3006-5489","authenticated-orcid":false,"given":"Luis Eduardo Rodrigues","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0637-0387","authenticated-orcid":false,"given":"Artur de Oliveira Macena","family":"L\u00f4bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1276-9535","authenticated-orcid":false,"given":"Iasmin Isabelli Luiz","family":"Silv\u00e9rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-6461","authenticated-orcid":false,"given":"Maria Eduarda Cavalcanti","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-8135","authenticated-orcid":false,"given":"Francisco Cezar Aquino","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-8399","authenticated-orcid":false,"given":"Maria Cristina Figueroa","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2024.07.011_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"International Immunopharmacology"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br J Hosp Med"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/genes15020145","article-title":"Genomic Variants and Worldwide Epidemiology of Breast Cancer: A Genome-Wide Association Studies Correlation Analysis","volume":"15","author":"Da Costa Nunes","year":"2024","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.clbc.2024.07.011_bib0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clinicians"},{"issue":"6","key":"10.1016\/j.clbc.2024.07.011_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3322\/caac.21754","article-title":"Breast Cancer Statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.clbc.2024.07.011_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1352224","article-title":"Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4\/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis","volume":"15","author":"Moraes","year":"2024","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.clbc.2024.07.011_bib0007","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000503219","article-title":"Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries","volume":"14","author":"Dafni","year":"2019","journal-title":"Breast Care"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0008","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci Data"},{"issue":"5","key":"10.1016\/j.clbc.2024.07.011_bib0009","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/jpm14050464","article-title":"Cyclin-Dependent Kinase 4\/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials","volume":"14","author":"Moraes","year":"2024","journal-title":"JPM"},{"issue":"27","key":"10.1016\/j.clbc.2024.07.011_bib0010","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.clbc.2024.07.011_bib0011","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.breast.2023.01.002","article-title":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","volume":"67","author":"Reimer","year":"2023","journal-title":"The Breast"},{"issue":"10","key":"10.1016\/j.clbc.2024.07.011_bib0012","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1055\/a-1904-6231","article-title":"AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022","volume":"82","author":"Banys-Paluchowski","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"10.1016\/j.clbc.2024.07.011_bib0013","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.clbc.2017.09.001","article-title":"The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era","volume":"18","author":"Mann","year":"2018","journal-title":"Clinical Breast Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2024.07.011_bib0014","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.07.011_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjsurg.2014.08.009","article-title":"Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?","volume":"208","author":"Robinson","year":"2014","journal-title":"The American Journal of Surgery"},{"issue":"3","key":"10.1016\/j.clbc.2024.07.011_bib0016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.breast.2013.02.001","article-title":"Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) \u2013 ACOSOG Z0011 results and beyond","volume":"22","author":"Gatzemeier","year":"2013","journal-title":"The Breast"},{"issue":"5","key":"10.1016\/j.clbc.2024.07.011_bib0017","first-page":"537","article-title":"The role of nodal staging in breast cancer. Past, present and future","volume":"65","author":"Hirche","year":"2010","journal-title":"Minerva Chir"},{"issue":"5","key":"10.1016\/j.clbc.2024.07.011_bib0018","first-page":"693","article-title":"Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?","volume":"59","author":"Marrazzo","year":"2007","journal-title":"Chir Ital"},{"key":"10.1016\/j.clbc.2024.07.011_bib0019","series-title":"StatPearls","article-title":"Axillary Lymphadenectomy","author":"Toomey","year":"2024"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.adro.2019.09.006","article-title":"Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy","volume":"5","author":"Ling","year":"2020","journal-title":"Advances in Radiation Oncology"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tbj.13720","article-title":"Twenty-five years of change in the management of the axilla in breast cancer","volume":"26","author":"Dixon","year":"2020","journal-title":"Breast J"},{"issue":"30","key":"10.1016\/j.clbc.2024.07.011_bib0022","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0023","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.1992.230","article-title":"Assessment of morbidity from complete axillary dissection","volume":"66","author":"Ivens","year":"1992","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2024.07.011_bib0024","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00228-024-03713-6","article-title":"Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials","volume":"80","author":"De Moraes","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clbc.2024.07.011_bib0025","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.clbc.2024.07.011_bib0026","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.clbc.2024.07.011_bib0027","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2024.07.011_bib0028","unstructured":"Definition of relapse-free survival - NCI Dictionary of Cancer Terms - NCI. February 2, 2011. Accessed September 17, 2024. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/relapse-free-survival"},{"key":"10.1016\/j.clbc.2024.07.011_bib0029","unstructured":"Definition of overall survival - NCI Dictionary of Cancer Terms - NCI. February 2, 2011. Accessed September 17, 2024. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/overall-survival"},{"key":"10.1016\/j.clbc.2024.07.011_bib0030","unstructured":"Definition of disease-free survival - NCI Dictionary of Cancer Terms - NCI. February 2, 2011. Accessed September 17, 2024. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/disease-free-survival"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jrsm.1140","article-title":"An empirical comparison of heterogeneity variance estimators in 12\u2009894 meta-analyses","volume":"6","author":"Langan","year":"2015","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jrsm.1198","article-title":"Comparative performance of heterogeneity variance estimators in meta-analysis: a review of simulation studies","volume":"8","author":"Langan","year":"2017","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0034","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clbc.2024.07.011_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.breast.2022.02.013","article-title":"Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial","volume":"63","author":"Appelgren","year":"2022","journal-title":"The Breast"},{"issue":"12","key":"10.1016\/j.clbc.2024.07.011_bib0036","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial","volume":"41","author":"Bartels","year":"2023","journal-title":"JCO"},{"issue":"12","key":"10.1016\/j.clbc.2024.07.011_bib0037","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/j.clbc.2024.07.011_bib0038","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"The Lancet Oncology"},{"issue":"10","key":"10.1016\/j.clbc.2024.07.011_bib0039","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"The Lancet Oncology"},{"issue":"3","key":"10.1016\/j.clbc.2024.07.011_bib0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Annals of Surgery"},{"issue":"6","key":"10.1016\/j.clbc.2024.07.011_bib0041","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clbc.2024.07.011_bib0042","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Annals of Surgery"},{"issue":"10","key":"10.1016\/j.clbc.2024.07.011_bib0043","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.clbc.2024.07.011_bib0044","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases","volume":"390","author":"De Boniface","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clbc.2024.07.011_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"The Lancet Oncology"},{"issue":"24","key":"10.1016\/j.clbc.2024.07.011_bib0046","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.clbc.2024.07.011_bib0047","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"Journal of Surgical Oncology"},{"issue":"9","key":"10.1016\/j.clbc.2024.07.011_bib0048","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1\u20132 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2024.07.011_bib0049","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/bjs\/znad215","volume":"110","author":"Tinterri","year":"2023","journal-title":"British Journal of Surgery"},{"issue":"5","key":"10.1016\/j.clbc.2024.07.011_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clbc.2013.04.004","article-title":"Does the Result of Completion Axillary Lymph Node Dissection Influence the Recommendation for Adjuvant Treatment in Sentinel Lymph Node\u2013Positive Patients?","volume":"13","author":"S\u00e1volt","year":"2013","journal-title":"Clinical Breast Cancer"},{"issue":"49","key":"10.1016\/j.clbc.2024.07.011_bib0051","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1556\/OH.2013.29765","article-title":"Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial","volume":"154","author":"S\u00e1volt","year":"2013","journal-title":"Orvosi Hetilap"},{"key":"10.1016\/j.clbc.2024.07.011_bib0052","unstructured":"76. Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer patients (surgery versus radiotherapy)\u2013OTOASOR trial: 5 years follow-up of a randomized clinical trial - ClinicalKey. Accessed September 17, 2024. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S0748798314006490?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0748798314006490%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ejso.com%2Farticle%2FS0748-7983(14)00649-0%2Fpdf."},{"issue":"4","key":"10.1016\/j.clbc.2024.07.011_bib0053","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla \u2013 Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0054","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12893-023-02101-8","article-title":"Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Surg"},{"issue":"1","key":"10.1016\/j.clbc.2024.07.011_bib0056","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","article-title":"Regional Recurrence in Breast Cancer Patients With Sentinel Node Micrometastases and Isolated Tumor Cells","volume":"255","author":"Pepels","year":"2012","journal-title":"Annals of Surgery"}],"updated-by":[{"DOI":"10.1016\/j.clbc.2024.07.011","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}},{"DOI":"10.1016\/j.clbc.2026.03.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:25:47Z","timestamp":1754551547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1526820924002118"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.07.011","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.clbc.2024.07.011","asserted-by":"object"}]},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Omitting axillary lymph node dissection is associated with an increased risk of regional recurrence in early stage breast cancer: a systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}